- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02472301
The Impact of Legumes vs Corn-soy Flour on Environmental Enteric Dysfunction in Rural Malawian Children 1-3 Year Olds
May 10, 2017 updated by: Washington University School of Medicine
Randomized, Single-blinded, Prospective Clinical Trial Comparing the Impact of Legumes vs Corn-soy Flour on Environmental Enteric Dysfunction and Stunting in Rural Malawian Children 1-3 Year Olds
To determine if 12 months of legume-based complementary foods is effective in reducing or reversing EED and linear growth faltering in a cohort of Malawian children, aged 12-35 months to see if these improvements are correlated with specific changes in the enteric microbiome.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
337
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Blantyre, Malawi
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
2 years to 6 months (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- children residing in catchment area of Limela, Machinga District and N tenda (Chikwawa District), Malawi
- aged 12-35 months
- youngest eligible child in each household
Exclusion Criteria:Unable to drink 20 mL of sugar water
- Demonstrating evidence of severe acute malnutrition, WHZ < or = -3, presence of bi-pedal pitting edema
- Apparent need for acute medical treatment for an illness or injury
- Caregiver refusal to participate and return for 3, 6 and 12 month follow-ups
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Cowpeas
Cowpea supplementary food that will be approximately 15% of the calculated total daily intake.
Children will receive the food for 12 months.
|
cowpeas supplementary food that will be approximately 15% of the calculated total daily intake.
Children will receive the food for 12 months.
|
|
Experimental: Common bean
Common bean supplementary food that will be approximately 15% of the calculated total daily intake.
Children will receive the food for 12 months.
|
common bean supplementary food that will be approximately 15% of the calculated total daily intake.
Children will receive the food for 12 months.
|
|
Active Comparator: Corn Soy Flour
Corn flour with 10% soy supplementary food that will be approximately 15% of the calculated total daily intake.
Children will receive the food for 12 months.
|
Corn-soy flour supplementary food that will be approximately 15% of the calculated total daily intake.
Children will receive the food for 12 months.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dual Sugar Absorption Test
Time Frame: 3 months
|
lactulose-mannitol ratio in urine
|
3 months
|
|
Dual Sugar Absorption Test
Time Frame: 6 months
|
lactulose-mannitol ratio in urine
|
6 months
|
|
Dual Sugar Absorption Test
Time Frame: 12 months
|
lactulose-mannitol ratio in urine
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Lactulose Excretion
Time Frame: 3 months
|
percentage of ingested lactulose excreted in urine
|
3 months
|
|
Lactulose Excretion
Time Frame: 6 months
|
percentage of ingested lactulose excreted in urine
|
6 months
|
|
Lactulose Excretion
Time Frame: 12 months
|
percentage of ingested lactulose excreted in urine
|
12 months
|
|
Mannitol Excretion
Time Frame: 3 months
|
percentage of ingested mannitol excreted in urine
|
3 months
|
|
Mannitol Excretion
Time Frame: 6 months
|
percentage of ingested mannitol excreted in urine
|
6 months
|
|
Mannitol Excretion
Time Frame: 12 months
|
percentage of ingested mannitol excreted in urine
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Kaimila Y, Pitman RT, Divala O, Hendrixson DT, Stephenson KB, Agapova S, Trehan I, Maleta K, Manary MJ. Development of Acute Malnutrition Despite Nutritional Supplementation in Malawi. J Pediatr Gastroenterol Nutr. 2019 May;68(5):734-737. doi: 10.1097/MPG.0000000000002241.
- Borresen EC, Zhang L, Trehan I, Nealon NJ, Maleta KM, Manary MJ, Ryan EP. The Nutrient and Metabolite Profile of 3 Complementary Legume Foods with Potential to Improve Gut Health in Rural Malawian Children. Curr Dev Nutr. 2017 Sep 21;1(10):e001610. doi: 10.3945/cdn.117.001610. eCollection 2017 Oct.
- Agapova SE, Stephenson KB, Divala O, Kaimila Y, Maleta KM, Thakwalakwa C, Ordiz MI, Trehan I, Manary MJ. Additional Common Bean in the Diet of Malawian Children Does Not Affect Linear Growth, but Reduces Intestinal Permeability. J Nutr. 2018 Feb 1;148(2):267-274. doi: 10.1093/jn/nxx013.
- Trehan I, Benzoni NS, Wang AZ, Bollinger LB, Ngoma TN, Chimimba UK, Stephenson KB, Agapova SE, Maleta KM, Manary MJ. Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children: study protocol for two randomized controlled trials. Trials. 2015 Nov 14;16:520. doi: 10.1186/s13063-015-1027-0.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2015
Primary Completion (Actual)
December 1, 2016
Study Completion (Actual)
December 1, 2016
Study Registration Dates
First Submitted
June 9, 2015
First Submitted That Met QC Criteria
June 10, 2015
First Posted (Estimate)
June 15, 2015
Study Record Updates
Last Update Posted (Actual)
May 11, 2017
Last Update Submitted That Met QC Criteria
May 10, 2017
Last Verified
May 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- LG2
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Environmental Enteropathy
-
Washington University School of MedicineUniversity of MalawiCompleted
-
Washington University School of MedicineCompleted
-
Tropical Gastroenterology & Nutrition Group (TROPGAN)Bill and Melinda Gates FoundationNot yet recruitingEnvironmental EnteropathyBangladesh, Pakistan, Senegal, Zambia
-
Institut Pasteur de DakarBill and Melinda Gates Foundation; Aga Khan University; International Centre... and other collaboratorsRecruitingEnvironmental Enteric DysfunctionSenegal
-
Children's Hospital Medical Center, CincinnatiUniversidade Federal do CearaCompletedDiarrhea | Malnutrition | Environmental EnteropathyBrazil
-
National Institute for Medical Research, TanzaniaLondon School of Hygiene and Tropical Medicine; University of Copenhagen; Queen...Active, not recruitingDiabetes | HIV | Environmental EnteropathyTanzania
-
Massachusetts General HospitalActive, not recruitingInflammatory Bowel Diseases | Crohn Disease | Permeability; Increased | Inflammatory Disease | Environmental EnteropathyUnited States
-
Regeneron PharmaceuticalsApproved for marketingCD55-Deficient Protein-Losing Enteropathy
-
Regeneron PharmaceuticalsCompletedCD55-deficient Protein-losing Enteropathy | CHAPLEUnited States, Thailand, Turkey (Türkiye)
-
Seoul National University HospitalCompletedFontan Operation | Protein-Losing Enteropathy | Camostat MesylateKorea, Republic of
Clinical Trials on cowpeas complementary food
-
International Centre for Diarrhoeal Disease Research...Washington University School of MedicineRecruiting
-
Research Institute of Child Nutrition, DortmundUniversity of Potsdam; Dr. von Hauner Children's Hospital, Germany; Pediatric...Completed
-
International Centre for Diarrhoeal Disease Research...Washington University School of MedicineUnknownNutrition | Microbiota | Complementary FoodBangladesh
-
International Centre for Diarrhoeal Disease Research...Washington University School of MedicineRecruiting
-
Johns Hopkins Bloomberg School of Public HealthInternational Centre for Diarrhoeal Disease Research, Bangladesh; United Nations... and other collaboratorsCompleted
-
Food and Nutrition Research Institute, PhilippinesInternational Atomic Energy Agency; Kamuzu University of Health Sciences; Rutgers... and other collaboratorsNot yet recruiting
-
International Centre for Diarrhoeal Disease Research...CompletedModerately Malnourished ChildrenBangladesh
-
Washington University School of MedicineCompleted
-
Nevin Scrimshaw International Nutrition FoundationUniversity of Ghana; Ghana Health Services; Ajinomoto USA, INC.; University of...CompletedGrowth Disorders | Micronutrient Deficiency | Infant Malnutrition | Protein Malnutrition | Morbidity;Infant
-
Suleyman Demirel UniversityNot yet recruitingPain | Anxiety | Patient Satisfaction